Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

30 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prognostic role of the innate immune signature CD163 and "eat me" signal calreticulin in clear cell renal cell carcinoma.
Anno T, Tanaka N, Takamatsu K, Hakozaki K, Kufukihara R, Baba Y, Takeda T, Matsumoto K, Morita S, Kosaka T, Mikami S, Nishihara H, Mizuno R, Oya M. Anno T, et al. Among authors: hakozaki k. Cancer Immunol Immunother. 2023 Jun;72(6):1779-1788. doi: 10.1007/s00262-023-03369-8. Epub 2023 Jan 17. Cancer Immunol Immunother. 2023. PMID: 36646952 Free PMC article.
Hochuekkito Combined with Pulmonary Rehabilitation in Apathetic Patients with Chronic Obstructive Pulmonary Disease: A Randomized Controlled Pilot Trial.
Hamada H, Sekikawa K, Okusaki K, Dodo T, Kagawa K, Sumigawa T, Awaya Y, Sakimoto N, Shioya S, Hakozaki K, Kadowaki T, Kakimoto M, Ito R, Kawamichi K, Kondo K, Namba H, Iwamoto H, Hattori N. Hamada H, et al. Among authors: hakozaki k. J Clin Med. 2022 Sep 26;11(19):5673. doi: 10.3390/jcm11195673. J Clin Med. 2022. PMID: 36233538 Free PMC article.
Oncological outcomes of dose reductions in cisplatin due to renal dysfunction for patients with metastatic urothelial carcinoma.
Murakami T, Kikuchi E, Ide H, Umezawa Y, Takahashi T, Izawa M, Hakozaki K, Shigeta K, Ogihara K, Kobayashi H, Kanai K, Maeda T, Yoshimine S, Mizuno R, Nishimoto K, Oya M. Murakami T, et al. Among authors: hakozaki k. BJUI Compass. 2021 Mar 9;2(5):322-330. doi: 10.1002/bco2.81. eCollection 2021 Sep. BJUI Compass. 2021. PMID: 35474877 Free PMC article.
Unique characteristics of tertiary lymphoid structures in kidney clear cell carcinoma: prognostic outcome and comparison with bladder cancer.
Masuda T, Tanaka N, Takamatsu K, Hakozaki K, Takahashi R, Anno T, Kufukihara R, Shojo K, Mikami S, Shinojima T, Kakimi K, Tsunoda T, Aimono E, Nishihara H, Mizuno R, Oya M. Masuda T, et al. Among authors: hakozaki k. J Immunother Cancer. 2022 Mar;10(3):e003883. doi: 10.1136/jitc-2021-003883. J Immunother Cancer. 2022. PMID: 35314433 Free PMC article.
30 results